New hope for patients and loved ones living with dementia (part 2)
There are new medications, including Leqembi, that slow the progression in early stages of the disease. Then there is new research that some common, treatable or manageable conditions are risk factors. Dr. Hugo Botha, an assistant professor of neurology with the Mayo Clinic detailed the importance of addressing these risk factors now.